文献速递生殖医学

儿童期造血干细胞移植后子宫体积显著减小,与预处理方案无关

The uterine volume is dramatically decreased after hematopoietic stem cell transplantation during childhood regardless of the conditioning regimen.
PubMed 文献 · Fertil Steril · 2023-01-07

法国13家大学教学医院的前瞻性队列研究,将88例儿童期因急性白血病接受造血干细胞移植的女性幸存者与对照组1:1匹配,通过集中双盲阅读的盆腔磁共振成像评估子宫体积。结果显示,无论烷化剂为基础还是全身照射为基础的预处理方案,子宫体积均较对照组显著减小,且全身照射组减小更明显。

要点

  • 儿童期造血干细胞移植后子宫体积显著减小,烷化剂组减小43.1%,全身照射组减小75.3%。
  • 烷化剂方案后,未用激素替代治疗的早发性卵巢功能不全者子宫体积较激素平衡者显著减小。
  • 全身照射方案后,激素替代治疗对子宫体积未见正向影响。

核心结论

  • 儿童期因急性白血病接受造血干细胞移植后,无论采用何种预处理方案,子宫体积均显著减小。

研究设计与样本

  • 前瞻性队列研究,纳入法国13家大学教学医院88例儿童期或青春期因急性白血病接受造血干细胞移植的女性幸存者,与对照组1:1匹配。
  • 盆腔磁共振成像包含弥散加权成像序列,扫描图像集中由2名放射科医生双盲阅读。

主要发现

  • 造血干细胞移植时平均年龄9.1±0.3岁,平均随访时间16.4±0.5年。
  • 88例幸存者中,烷化剂为基础预处理组34例,全身照射为基础预处理组54例;77例激素平衡(因早发性卵巢功能不全接受激素替代治疗或存在残余卵巢功能)。
  • 对照组(n=88)平均子宫体积79.7±3.3 mL;烷化剂组45.3±5.6 mL,较对照组显著减小43.1%(28.8%-57.4%);全身照射组19.6±1.9 mL,较对照组显著减小75.3%(70.5%-80.2%)。
  • 烷化剂方案后,未接受激素替代治疗的早发性卵巢功能不全者子宫体积15.2±2.6 mL,激素平衡者49.3±6 mL,前者显著减小。
  • 全身照射方案后,未接受激素替代治疗者子宫体积16.3±2.6 mL,激素平衡者20.1±2.2 mL,两组相似,激素替代治疗对子宫体积未见正向影响。

局限性

  • 作者在结论中提出需进一步研究其病理生理机制,包括大剂量烷化剂的特定影响、青春期前后激素剥夺的影响、激素替代治疗依从性差、或激素替代治疗与外源性卵巢雌激素对子宫肌层的不同影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the impact of hematopoietic stem cell transplantation (HSCT) on the uterine volume of childhood acute leukemia (AL) survivor depending on age at HSCT and the type of myeloablative conditioning regimen. SETTING: Thirteen French University Teaching Hospitals. DESIGN: Prospective cohort study. PATIENT(S): Eighty-eight women who underwent HSCT during childhood or adolescence for AL compared to a control group. INTERVENTION(S): A multicentric prospective national study compared the uterine volume in a cohort of childhood AL survivor adult women treated with HSCT, matched 1:1 to control women. Pelvic magnetic resonance imaging scans included diffusion-weighted imaging sequences. Scans were centralized for a double-blinded reading by 2 radiologists. MAIN OUTCOME MEASURE(S): Uterine volume, uterine body-to-cervix ratio, and apparent diffusion coefficient. RESULT(S): The mean age at HSCT was 9.1 ± 0.3 years with a mean follow-up duration of 16.4 ± 0.5 years. The cohort of 88 HSCT survivor women was composed of 2 subgroups depending on the myeloablative conditioning regimen received: an alkylating agent-based regimen group (n = 34) and a total body irradiation (TBI)-based regimen group (n = 54). Among the 88 women, 77 were considered as having a "correct hormonal balance" with estrogens supplied by hormone replacement therapy (HRT) for premature ovarian insufficiency (POI) or because of a residual ovarian function. In the control group (n = 88), the mean uterine volume was 79.7 ± 3.3 mL. The uterine volume significantly decreased in all HSCT survivor women. After the alkylating agent-based regimen, the uterine volume was 45.3 ± 5.6 mL, corresponding to a significant volume reduction of 43.1% (28.8-57.4%) compared with that of the control group. After TBI, the uterine volume was 19.6 ± 1.9 mL, corresponding to a significant volume reduction of 75.3% (70.5%-80.2%) compared with that of the control group. After the alkylating agent-based regimen, the uterine volume dramatically decreased in women with POI without HRT compared with that in those with a correct hormonal balance (15.2 ± 2.6 vs. 49.3 ± 6 mL). In contrast, after TBI, the uterine volume was similar in all women, with no positive effect of hormonal impregnation on the uterine volume (16.3 ± 2.6 vs. 20.1 ± 2.2 mL, respectively). CONCLUSION(S): The uterine volume was diminished after HSCT, regardless of the conditioning regimen. The physiopathology needs to be further investigated: specific impact of a high dose of an alkylating agent; impact of hormone deprivation around puberty; poor compliance to HRT; or different myometrial impact of HRT compared with endogenous ovarian estrogens? CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov/NCT03583294 (enrollment of the first subject, November 11, 2017; enrollment of the last subject, June 25, 2021).

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Courbiere B, Drikes B, Grob A, et al. The uterine volume is dramatically decreased after hematopoietic stem cell transplantation during childhood regardless of the conditioning regimen. Fertil Steril. 2023. PMID: 36627013. doi:10.1016/j.fertnstert.2022.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。